Literature DB >> 3416146

Thrombocytopenia in systemic lupus erythematosus responsive to dapsone.

C Moss1, P J Hamilton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3416146      PMCID： PMC1833929          DOI： 10.1136/bmj.297.6643.266

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis.

Authors:  O Stendahl; L Molin; C Dahlgren
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

2.  Dapsone and discoid lupus erythematosus.

Authors:  P R Coburn; S Shuster
Journal:  Br J Dermatol       Date:  1982-01       Impact factor: 9.302

3.  Annular subacute cutaneous lupus erythematosus responsive to dapsone.

Authors:  L S McCormack; M L Elgart; M L Turner
Journal:  J Am Acad Dermatol       Date:  1984-09       Impact factor: 11.527

4.  Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea-pig reactions.

Authors:  S I Katz; K C Hertz; P S Crawford; L A Gazze; M M Frank; T J Lawley
Journal:  J Invest Dermatol       Date:  1976-12       Impact factor: 8.551

5.  Dapsone in the treatment of lupus erythematosus.

Authors:  T Ruzicka; G Goerz
Journal:  Br J Dermatol       Date:  1981-01       Impact factor: 9.302
  5 in total
  7 in total

Review 1.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

2.  A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response.

Authors:  Marina P Colella; Fernanda A Orsi; Elizio C F Alves; Gabriela de F Delmoro; Gabriela G Yamaguti-Hayakawa; Erich V de Paula; Joyce M Annichino-Bizzacchi
Journal:  J Thromb Haemost       Date:  2021-08-09       Impact factor: 5.824

Review 3.  Treatment of Bullous Systemic Lupus Erythematosus.

Authors:  Lihua Duan; Liying Chen; Shan Zhong; Ying Wang; Yan Huang; Yan He; Jie Chen; Guixiu Shi
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

Review 4.  Haematological manifestations of lupus.

Authors:  Anum Fayyaz; Ann Igoe; Biji T Kurien; Debashish Danda; Judith A James; Haraldine A Stafford; R Hal Scofield
Journal:  Lupus Sci Med       Date:  2015-03-03

5.  Dapsone therapy for refractory immune thrombocytopenia patients: a case series.

Authors:  Ji Yun Lee; Jeong-Ok Lee; Joo Young Jung; Soo-Mee Bang
Journal:  Blood Res       Date:  2017-06-22

6.  Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar.

Authors:  Jaewoo Song
Journal:  Blood Res       Date:  2017-06-22

7.  Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.

Authors:  Clémentine Estève; Maxime Samson; Alexandre Guilhem; Barbara Nicolas; Vanessa Leguy-Seguin; Sabine Berthier; Bernard Bonnotte; Sylvain Audia
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.